Abstract:Objective Ovarian cancer (OC) accounts for the highest mortality rate among all gynecological malignancies. We intend to develop engineered exosomes to deliver the microRNA to inhibit the growth and progression of OC. Methods Extracellular vesicles (EV) secreted by OC cells were isolated and loaded with miR-494-3p by electroporation to prepare the engineered miR-494-3p EV. The morphology and size of miR-494-3p EV were identified using the Transmission Electron Microscope and Nanoparticle Tracing Analysis. Western blot (WB) was conducted to detect the exosomal markers including TSG101 and CD63. The loading efficiency was assessed by qRT-PCR. Exosomes labeled with PKH26 were used to study the specific uptake by OC cells. OVCAR3 and SKOV3 cells were treated with EV, miR-NC EV, and miR-494-3p EV, respectively. EdU assay was conducted to evaluate proliferation. The level of miR-494-3p in OC tissues and cell lines was detected by qRT-PCR. Flow cytometry was used to detect apoptosis. Scratching assay was applied to evaluate migration. Transwell assay was used to evaluate migration and invasion. The levels of apoptosis-related, migration-related, and invasion-related proteins were assessed by WB. Results The results of qRT-PCR showed that miR-494-3p was significantly lower expressed in OC tissues than in normal tissues. The same is true in OC cell lines. The results showed that miR-494-3p EV could be successfully absorbed by OVCAR3 and SKOV3 cells. The expression of miR-494-3p in miR-494-3p EV or miR-494-3p EV-treated OC cells was significantly increased. The results of the EdU experiment, scratch experiment, and Transwell experiment showed that miR-494-3p EV significantly inhibited the proliferation, migration, and invasion of OC cells. Flow cytometry results showed that miR-494-3p EV significantly increased OC cell apoptosis. These results were further verified by the WB experiment. Conclusions In summary, our study suggests that OC cell-derived miR-494-3p EV may play a role in the development of OC cells by inhibiting the proliferation, migration, and invasion of OC cells and promoting apoptosis. These findings may provide new therapeutic strategies for the clinical treatment of OC. Graphical abstract Download : Download high-res image (161KB) Download : Download full-size image

MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation

MiR-5195-3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer

MicroRNA-520g Promotes Epithelial Ovarian Cancer Progression and Chemoresistance Via DAPK2 Repression

Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway

Abstract 3582: Circular RNA Circplehm3 Acts As the Sponge of Microrna-9 to Suppress Ovarian Carcinoma Progression

Suppressed Mir-424 Expression Via Upregulation of Target Gene Chk1 Contributes to the Progression of Cervical Cancer

MicroRNA-204-5p Inhibits Ovarian Cancer Cell Proliferation by Down-Regulating USP47

MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A

LINC01088 Inhibits Tumorigenesis of Ovarian Epithelial Cells by Targeting Mir-24-1-5p

MiR-596 activated by EP300 controls the tumorigenesis in epithelial ovarian cancer by declining BRD4 and KPNA4

The Effect of Hsa-miR-504 Targeting MUC16 in Ovarian Cancer Progression

Bioinformatic analysis reveals MIR502 as a potential tumour suppressor in ovarian cancer

Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis

E74-like factor 3 suppresses microRNA-485-5p transcription to trigger growth and metastasis of ovarian cancer cells with the involvement of CLDN4/Wnt/β-catenin axis

MicroRNA-1179 Regulates Proliferation and Chemosensitivity of Human Ovarian Cancer Cells by Targeting the PTEN-mediated PI3K/AKT Signaling Pathway

MiR-509-3-5p Causes Aberrant Mitosis and Anti-Proliferative Effect by Suppression of PLK1 in Human Lung Cancer A549 Cells

Extracellular vesicle loaded with miR-494-3p can suppress ovarian cancer cell

Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis

Targeting of KDM5A by miR-421 in Human Ovarian Cancer Suppresses the Progression of Ovarian Cancer Cells

MiR-30a-5p/CHD1 axis enhances cisplatin sensitivity of ovarian cancer cells via inactivating the Wnt/β-catenin pathway

microRNA-671-5p reduces tumorigenicity of ovarian cancer via suppressing HDAC5 and HIF-1α expression